56. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie e. V. (DGNC)
3èmes journées françaises de Neurochirurgie (SFNC)
Deutsche Gesellschaft für Neurochirurgie e. V.
Société Française de Neurochirurgie
07. bis 11.05.2005, Strasbourg
Lectures 10.05.
10.05.-09 Glioma 4
Meeting Abstract
(10.05.-09.01)
[Full Text]
Prognostic value of amino-acid PET with FET in 85 patients with newly diagnosed glioma-suspicious intracerebral lesions
Floeth F, Reifenberger G, Langen KJ, Pauleit D, Steiger HJ, Sabel M[Full Text]
Meeting Abstract
(10.05.-09.02)
[Full Text]
MGMT methylation as a potential outcome predictor in patients with malignant gliomas treated with adjuvant temozolomide chemotherapy
Luyken C, Loeser S, Willers R, Steiger H, Reifenberger G, Sabel M[Full Text]
Meeting Abstract
(10.05.-09.03)
[Full Text]
Investigation of interaction between neuroepithelial brain tumours and surrounding brain parenchyma based on neural cell adhesion molecule
Kuhn SA, Ebmeier K, Brodhun M, Reichart R, Katenkamp D, Kalff R[Full Text]
Meeting Abstract
(10.05.-09.04)
[Full Text]
High predictive value of hemizygous deletions at the Notch2 locus for survival of primary brain tumour patients
Zweifel C, Boulay JL, Miserez AR, Ghaffari A, Reifenberger G, Merlo A[Full Text]
Meeting Abstract
(10.05.-09.05)
[Full Text]
Inhibition of intracerebral glioblastoma growth by treatment with a novel one-armed anti-MET antibody
Martens T, Schmidt NO, Eckerich C, Fillbrandt R, Schwall R, Westphal M, Lamszus K[Full Text]
Meeting Abstract
(10.05.-09.06)
[Full Text]
Gene therapy for high-grade glioma with an adenoviral vector containing the Herpes Simplex virus thymidine kinase gene (Cerepro™)
Sandmair AM, Vapalahti M, Immonen A, Tynnela K, Hurskainen H, Vanninen R, Langford G, Murray N, Ylä-Herttuala HS[Full Text]